Previous 10 | Next 10 |
A look at the top 10 most actives in the United States Pineapple Energy Inc. (PEGY) rose 62.0% to $0.0841 on volume of 152,172,157 shares Biodexa Pharmaceuticals plc (BDRX) rose 83.5% to $1.33 on volume of 33,556,403 shares Kintara Therapeutics Inc. (KTRA) rose 9.5% to $0.173 on volume of...
MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 sha...
2024-04-23 07:34:04 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re diving into the biggest pre-market stock movers that traders need to know about on Tuesday morning! Moving stocks this morning are delisting updates, proposed public offerings,...
MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy to heart failure patients suffering from fluid overload using the company’s Aquadex SmartF...
- Analysis demonstrates the statistically superior benefits of ultrafiltration therapy in heart failure events and heart failure hospitalizations compared to intravenous loop diuretics - Artificial intelligence and machine learning-based model show that lifestyle and clinical factors c...
2024-03-05 12:11:13 ET Nuwellis, Inc. (NUWE) Q4 2023 Results Conference Call March 05, 2024 9:00 AM ET Company Participants Vivian Cervantes - IR Nestor Jaramillo - President, CEO Rob Scott - CFO John Jefferies - CMO Conference Call Participants J...
2024-03-05 08:14:52 ET More on Nuwellis Seeking Alpha’s Quant Rating on Nuwellis Historical earnings data for Nuwellis Financial information for Nuwellis Read the full article on Seeking Alpha For further details see: Nuwellis GAAP EPS of -...
MINNEAPOLIS, March 05, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today reported financial results for the fourth quarter and full year ended December 31, 2023. Highlights: Rec...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...
MINNEAPOLIS, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced that it will release financial results for the fourth quarter and full year of 2023 on Tuesday, March 5, 2024...
News, Short Squeeze, Breakout and More Instantly...
MINNEAPOLIS, July 17, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients suffering from fluid overload, is proud to announce its first commercial sale of QUELIMMUNE™, a novel therapy developed by SeaS...
DENVER, July 12, 2024 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU) (SeaStar Medical) reports the initial commercial sale of QUELIMMUNE ™ -Pediatric to its U.S. license and distribution partner, Nuwellis, Inc. QUELIMMUNE is SeaStar Medical’s Sel...
MINNEAPOLIS, July 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company dedicated to transforming the lives of patients with fluid overload, is pleased to announce that new clinical evidence demonstrating the efficacy of its Aquadex ...